Drug Information
Drug General Information | Top | |||
---|---|---|---|---|
Drug ID |
D04AXY
|
|||
Former ID |
DNC012608
|
|||
Drug Name |
6-(4-Methyl-piperazin-1-yl)-phenanthridine
|
|||
Synonyms |
CHEMBL43193; 23441-13-6; 6-(4-methylpiperazin-1-yl)phenanthridine; 6-(4-Methyl-piperazin-1-yl)-phenanthridine; CTK0I7937; DTXSID50433889; ZINC13778637; BDBM50063258; 6-(4-Methylpiperazino)phenanthridine; Phenanthridine, 6-(4-methyl-1-piperazinyl)-
Click to Show/Hide
|
|||
Drug Type |
Small molecular drug
|
|||
Indication | Discovery agent [ICD-11: N.A.] | Investigative | [1] | |
Structure |
Download2D MOL |
|||
Formula |
C18H19N3
|
|||
Canonical SMILES |
CN1CCN(CC1)C2=NC3=CC=CC=C3C4=CC=CC=C42
|
|||
InChI |
1S/C18H19N3/c1-20-10-12-21(13-11-20)18-16-8-3-2-6-14(16)15-7-4-5-9-17(15)19-18/h2-9H,10-13H2,1H3
|
|||
InChIKey |
ZVJIBTNUNUXAIO-UHFFFAOYSA-N
|
|||
CAS Number |
CAS 23441-13-6
|
|||
PubChem Compound ID |
Target and Pathway | Top | |||
---|---|---|---|---|
Target(s) | 5-HT 3A receptor (HTR3A) | Target Info | Inhibitor | [1] |
5-HT 3B receptor (HTR3B) | Target Info | Inhibitor | [1] | |
KEGG Pathway | Serotonergic synapse | |||
NetPath Pathway | IL2 Signaling Pathway | |||
Panther Pathway | 5HT3 type receptor mediated signaling pathway | |||
Reactome | Ligand-gated ion channel transport | |||
WikiPathways | SIDS Susceptibility Pathways | |||
Iron uptake and transport |
References | Top | |||
---|---|---|---|---|
REF 1 | Novel potent and selective central 5-HT3 receptor ligands provided with different intrinsic efficacy. 2. Molecular basis of the intrinsic efficacy ... J Med Chem. 1999 May 6;42(9):1556-75. |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.